Persephone
Founded 2017 · 16 employees on LinkedIn · 4 known investors
Find your way into Persephone
159 people in our graph share verified history with the Persephone team — schools, employers, funds. One of them is your warm intro.
Persephone develops a synbiotic supplement for infants that combines probiotics (keystone Bifidobacterium strains) with prebiotics found in human breast milk to replenish gut bacteria linked to digestion, immunity, and development. The product was developed by microbiome scientists and pediatricians and validated in a clinical study.
Founders & leadership
Persephone was founded in 2017 by Stephanie Culler and Steve Van Dien.


Investors · 4
Founder mafia
2 people who came through Persephone went on to found or lead other companies.
Competitors · 3
by search overlapCompanies competing with Persephone for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Persephone do?
- Persephone develops a synbiotic supplement for infants that combines probiotics (keystone Bifidobacterium strains) with prebiotics found in human breast milk to replenish gut bacteria linked to digestion, immunity, and development. The product was developed by microbiome scientists and pediatricians and validated in a clinical study.
- Who founded Persephone?
- Persephone was founded by Stephanie Culler, Steve Van Dien in 2017.
- Who are Persephone's investors?
- Persephone's investors include First Bight Ventures, Propel Bio Partners, Fifty Years, Y Combinator.








